Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 11, 2019 4:00 P.M.
Form: S-1
CIK: 0001169245
Company Name: PhaseBio Pharmaceuticals Inc
File Number: 333-230783